Fulton Breakefield Broenniman LLC Danaher Corp Transaction History

Fulton Breakefield Broenniman LLC

$1.38 Billion
Q4 2024

A detailed history of Fulton Breakefield Broenniman LLC transactions in Danaher Corp stock. As of the latest transaction made, Fulton Breakefield Broenniman LLC holds 99,755 shares of DHR stock, worth $20.6 Million. This represents 1.66% of its overall portfolio holdings.

Number of Shares

99,755

Previous 99,670 0.09%

Holding current value

$20.6 Million

Previous $27.7 Million 17.36%

% of portfolio

1.66%

Previous 1.97%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	BUY	$226.16 - $274.52 $19,223 - $23,334	85 Added 0.09%	99,755 $22.9 Million
Q3 2024 Oct 16, 2024	SELL	$239.25 - $280.76 $413,663 - $485,434	-1,729 Reduced 1.71%	99,670 $27.7 Million
Q2 2024 Aug 07, 2024	SELL	$235.51 - $267.98 $97,972 - $111,479	-416 Reduced 0.41%	101,399 $25.3 Million
Q1 2024 Apr 29, 2024	SELL	$224.58 - $256.19 $138,790 - $158,325	-618 Reduced 0.6%	101,815 $25.4 Million
Q4 2023 Feb 02, 2024	BUY	$185.1 - $233.13 $74,780 - $94,184	404 Added 0.4%	102,433 $23.7 Million
Q3 2023 Oct 20, 2023	BUY	$233.08 - $265.59 $115,607 - $131,732	496 Added 0.49%	102,029 $25.3 Million
Q2 2023 Jul 19, 2023	BUY	$224.99 - $256.14 $432,205 - $492,044	1,921 Added 1.93%	101,533 $24.4 Million
Q1 2023 Apr 25, 2023	BUY	$239.75 - $277.0 $461,758 - $533,502	1,926 Added 1.97%	99,612 $25.1 Million
Q4 2022 Jan 31, 2023	BUY	$241.42 - $282.29 $444,937 - $520,260	1,843 Added 1.92%	97,686 $25.9 Million
Q3 2022 Oct 17, 2022	SELL	$247.06 - $1507.4 $53,364 - $325,598	-216 Reduced 0.22%	95,843 $24.8 Million
Q2 2022 Jul 28, 2022	SELL	$237.11 - $299.66 $13,752 - $17,380	-58 Reduced 0.06%	96,059 $24.4 Million
Q1 2022 Apr 27, 2022	BUY	$257.27 - $315.76 $976,596 - $1.2 Million	3,796 Added 4.11%	96,117 $28.2 Million
Q4 2021 Feb 07, 2022	BUY	$292.08 - $329.01 $191,020 - $215,172	654 Added 0.71%	92,321 $30.4 Million
Q3 2021 Oct 25, 2021	SELL	$272.21 - $332.43 $3.94 Million - $4.81 Million	-14,478 Reduced 13.64%	91,667 $27.9 Million
Q2 2021 Jul 27, 2021	BUY	$225.08 - $271.69 $507,105 - $612,117	2,253 Added 2.17%	106,145 $28.5 Million
Q1 2021 Apr 09, 2021	BUY	$212.38 - $245.9 $3.67 Million - $4.25 Million	17,273 Added 19.94%	103,892 $23.4 Million
Q4 2020 Jan 14, 2021	SELL	$212.5 - $245.46 $2.88 Million - $3.33 Million	-13,563 Reduced 13.54%	86,619 $19.2 Million
Q3 2020 Oct 20, 2020	BUY	$177.16 - $215.33 $97,260 - $118,216	549 Added 0.55%	100,182 $21.6 Million
Q2 2020 Jul 10, 2020	BUY	$128.7 - $176.83 $505,662 - $694,765	3,929 Added 4.11%	99,633 $17.6 Million
Q1 2020 Apr 10, 2020	BUY	$121.39 - $169.05 $230,641 - $321,195	1,900 Added 2.03%	95,704 $13.2 Million
Q4 2019 Jan 14, 2020	BUY	$133.47 - $153.48 $46,714 - $53,718	350 Added 0.37%	93,804 $14.4 Million
Q3 2019 Oct 17, 2019	BUY	$135.4 - $146.47 $74,605 - $80,704	551 Added 0.59%	93,454 $13.5 Million
Q2 2019 Jul 25, 2019	BUY	$124.88 - $143.73 $371,018 - $427,021	2,971 Added 3.3%	92,903 $13.3 Million
Q1 2019 Apr 17, 2019	SELL	$97.62 - $132.29 $122,805 - $166,420	-1,258 Reduced 1.38%	89,932 $11.9 Million
Q4 2018 Feb 05, 2019	SELL	$94.85 - $109.54 $71,422 - $82,483	-753 Reduced 0.82%	91,190 $9.4 Million
Q3 2018 Oct 24, 2018	BUY	$98.13 - $108.9 $42,980 - $47,698	438 Added 0.48%	91,943 $9.99 Million
Q2 2018 Aug 02, 2018	BUY	$96.1 - $103.24 $170,481 - $183,147	1,774 Added 1.98%	91,505 $9.03 Million
Q1 2018 Apr 19, 2018	SELL	$92.16 - $103.8 $75,294 - $84,804	-817 Reduced 0.9%	89,731 $8.79 Million
Q4 2017 Jan 30, 2018	SELL	$85.26 - $94.62 $33,166 - $36,807	-389 Reduced 0.43%	90,548 $8.41 Million
Q3 2017 Oct 13, 2017	BUY	$79.29 - $88.45 $7.21 Million - $8.04 Million	90,937	90,937 $7.8 Million

Others Institutions Holding DHR

# of Institutions

2,525

Shares Held

550M

Call Options Held

7.1M

Put Options Held

5.14M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $150B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulton Breakefield Broenniman LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fulton Breakefield Broenniman LLC with notifications on news.

Account

Fulton Breakefield Broenniman LLC Danaher Corp Transaction History